Table 1.
Baseline cardiometabolic profile.
| Parameters | Placebo (n = 19) | Supplement (n = 21) |
|---|---|---|
| Weight (kg) | 78.20 ± 15.42 | 78.30 ± 13.12 |
| BMI (kg/m2) | 28.70 ± 5.0 | 30.0 ± 3.3 |
| Body fat (%) | 37.20 ± 6.63 | 35.80 ± 6.08 |
| Waist circumference (cm) | 93.90 ± 11.15 | 97.90 ± 10.04 |
| Systolic blood pressure (mmHg) | 112.5 ± 10.54 | 116.0 ± 12.52 |
| Diastolic blood pressure (mmHg) | 70.50 ± 7.77 | 77.00 ± 9.22 |
| Triglyceridemia (mg/dl) | 128.4 ± 55.91 | 116.7 ± 85.98 |
| Glycemia (mg/dl) | 80.60 ± 12.44 | 86.60 ± 21.65 |
| Serum uric acid (mg/dl) | 4.40 ± 1.20 | 4.70 ± 3.51 |
| Total antioxidant status (mmol/L) | 2.40 ± 1.14 | 2.20 ± 0.66 |